AmorePacific EBIT per Share
The EBIT per Share of AmorePacific (090430.KS) as of Aug 15, 2026 is 3,196.73 KRW. In the previous year, EBIT per Share was 1,567.22 KRW — a change of 103.97% (higher).
Get this data via API
Financial Data API
EBIT per Share
3,196.73KRW
YoY
103.97%
Last updated:
EBIT per Share of AmorePacific is 2026 3,196.73 KRW. EBIT per Share of AmorePacific was 2025 1,567.22 KRW. It decreases by 103.97% higher compared to the previous year.
Access this data via the Eulerpool API
AmorePacific Stock analysis
What does AmorePacific do? AmorePacific Corp is a South Korean company that originated in 1945. Over the years, it has become a market leader as a manufacturer of cosmetic products. The company is known for its specialization in beauty products based on traditional Korean natural medicine. It has established itself as a globally recognized brand through its clear focus on quality, innovation, and sustainability. AmorePacific Corp's business model is based on the production and marketing of various types of cosmetic products. It operates in different industries and offers customers a wide range of beauty and skincare products, including face care, makeup, hair care, body care, and high-tech products. The company operates globally and has branches in more than 30 countries worldwide. In 2020, it had a revenue of approximately USD 6.1 billion. AmorePacific Corp is divided into various divisions to cover its wide range of products. The most well-known divisions are AmorePacific, Sulwhasoo, Laneige, Innisfree, Etude, Primera, Espoir, and Ryo, each specializing in certain product categories. For example, AmorePacific specializes in high-quality anti-aging and niche products, while Sulwhasoo focuses on Asian herbal medicine cosmetics. One of AmorePacific's most famous products is the Green Tea Seed Cream, which incorporates the health-promoting properties of green tea into skincare products. It is the best-selling product of Innisfree, a division of AmorePacific, and has proven to be one of the company's most successful products. Another successful product line is Sulwhasoo, specializing in Asian herbal medicine cosmetics and focusing on restoring and strengthening the skin. Sulwhasoo products are tailored to the needs of Asian skin and are appreciated by women worldwide. The Sulwhasoo line also features the legendary Concentrated Ginseng Renewing Serum, formulated with high-end ingredients like ginseng root extracts to provide firmer and more radiant skin. In addition to developing innovative products, AmorePacific Corp has also made extensive efforts in sustainability. The company is committed to minimizing its environmental impact by promoting waste and energy savings. It has launched initiatives to support local communities and is dedicated to corporate social responsibility. In summary, AmorePacific Corp is a leading company in the cosmetics industry. Through its focus on quality, innovation, and sustainability, it has become a globally recognized brand known for its wide range of beauty products. With its various divisions and brands, AmorePacific appeals to a diverse range of consumers worldwide. AmorePacific is one of the most popular companies on Eulerpool.
Frequently Asked Questions about AmorePacific stock
EBIT per Share of AmorePacific is 3,196.73 KRW in 2026.
EBIT per Share of AmorePacific changed from 1,567.22 KRW to 3,196.73 KRW, representing a 103.97% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of EBIT per Share AmorePacific since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
Income Statement — AmorePacific
All Key Metrics — AmorePacific
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth